ANF 29.50 Abercrombie & Fitch Company $ANF Hit a 52 week

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
ANF 29.50 Abercrombie & Fitch Company $ANF Hit a 52 week low of 29.25 Currently at 29.50 -5.88 -16.62% With a day low of 29.25 and a total volume of 14,568,399.

ANF Abercrombie & Fitch Company Recent Headline News

'Fast Money' Recap: When Is the Best Time to Buy Twitter Stock?
at The Street - Sat Nov 08, 4:00AM CST
The trading panel discussed whether it would help or hurt Twitter if its CEO steps down and whether Coca-Cola has any fizz left in it.
KO: 42.32 (+0.03), YHOO: 48.55 (+0.62), MNST: 108.39 (+7.91), ANF: 29.50 (-5.88), SLXP: 91.47 (-47.08), FFIV: 126.66 (+1.45), AKS: 6.62 (+0.48), TWTR: 40.31 (-0.53), GDX: 18.64 (+1.43), FXF: 101.10 (+0.79)

Abercrombie warns on Q3
at Investor's Business Daily - Fri Nov 07, 5:36PM CST
The young men's and women's apparel retailer is still having trouble getting teens to buy its clothing. Abercrombie & Fitch (ANF), which faces tough competition from rivals such as Forever 21 and H&M, said in a Q3 update that net sales fell 12% to...
ANF: 29.50 (-5.88)

NYSE stocks posting largest percentage decreases
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at the close of trading:
PNK: 22.85 (-0.37), CZZ: 9.42 (+0.08), PBH: 32.79 (-4.53), TCAP: 23.47 (+0.96), MED: 29.77 (-3.04), AMBR: 11.40 (-2.21), ANF: 29.50 (-5.88), NSM: 29.83 (+1.96), NKA: 5.41 (-0.54), GNW: 8.41 (-0.25), HGR: 19.88 (-4.31), KOP: 32.47 (+0.25)

Abercrombie & Fitch Set to Possibly Rebound After Yesterday's Selloff of 16.62%
Comtex SmarTrend(R) - Fri Nov 07, 3:45PM CST
Abercrombie & Fitch (NYSE:ANF) traded in a range yesterday that spanned from a low of $29.25 to a high of $31.55. Yesterday, the shares fell 16.6%, which took the trading range below the 3-day low of $31.90 on volume of 14.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ANF: 29.50 (-5.88)

SmarTrend Watching for Potential Rebound in Shares of Abercrombie & Fitch After 16.62% Loss
Comtex SmarTrend(R) - Fri Nov 07, 3:44PM CST
Abercrombie & Fitch (NYSE:ANF) traded in a range yesterday that spanned from a low of $29.25 to a high of $31.55. Yesterday, the shares fell 16.6%, which took the trading range below the 3-day low of $31.90 on volume of 14.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ANF: 29.50 (-5.88)


Abercrombie & Fitch reports sharp drop in sales
AP - Fri Nov 07, 9:43AM CST
NEW YORK (AP) — Abercrombie & Fitch is still having trouble getting teens to buy its clothing.
ANF: 29.50 (-5.88)

Abercrombie & Fitch (ANF) Stock Plummeting Today After Earnings Update
at The Street - Fri Nov 07, 9:11AM CST
Abercrombie & Fitch (ANF) stock is plunging after the company issued a guidance warning for the 2014 third quarter.
ANF: 29.50 (-5.88)

ABERCROMBIE & FITCH PROVIDES THIRD QUARTER BUSINESS UPDATE
Thomson Reuters ONE - Fri Nov 07, 7:01AM CST
New Albany, Ohio, November 7, 2014: Abercrombie & Fitch (NYSE: ANF) today provided a business update on the Company's performance for the third quarter ended November 1, 2014.
ANF: 29.50 (-5.88)

Shares of ANF Down 14.4% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Nov 03, 11:13AM CST
SmarTrend identified a Downtrend for Abercrombie & Fitch (NYSE:ANF) on September 22nd, 2014 at $38.86. In approximately 1 month, Abercrombie & Fitch has returned 14.45% as of today's recent price of $33.25.
ANF: 29.50 (-5.88)

Newell Beats Q3 Earnings, Expands Project Renewal Program - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 10:45AM CDT
Newell Rubbermaid Inc. (NWL) posted third-quarter 2014 adjusted earnings of 58 cents a share that surpassed the Zacks Consensus Estimate of 55 cents and rose 11.5% year over year.
WDFC: 77.09 (-0.47), LB: 75.61 (-0.74), NWL: 34.80 (+0.08), ANF: 29.50 (-5.88)

Look for Shares of Abercrombie & Fitch to Potentially Pullback after Yesterday's 2.00% Rise
Comtex SmarTrend(R) - Wed Oct 29, 4:48PM CDT
Abercrombie & Fitch (NYSE:ANF) traded in a range yesterday that spanned from a low of $32.79 to a high of $33.87. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $33.06 on volume of 3.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ANF: 29.50 (-5.88)

Abercrombie & Fitch Rises 2.00% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Oct 29, 4:46PM CDT
Abercrombie & Fitch (NYSE:ANF) traded in a range yesterday that spanned from a low of $32.79 to a high of $33.87. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $33.06 on volume of 3.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ANF: 29.50 (-5.88)

Abercrombie & Fitch Has Returned 18.9% Since SmarTrend Recommendation (ANF)
Comtex SmarTrend(R) - Mon Oct 27, 9:54AM CDT
SmarTrend identified a Downtrend for Abercrombie & Fitch (NYSE:ANF) on September 22nd, 2014 at $38.86. In approximately 1 month, Abercrombie & Fitch has returned 18.92% as of today's recent price of $31.51.
ANF: 29.50 (-5.88)

After Yesterday's Decline of 5.71%, Abercrombie & Fitch Offers Investors Better Value
Comtex SmarTrend(R) - Fri Oct 24, 5:40PM CDT
Abercrombie & Fitch (NYSE:ANF) traded in a range yesterday that spanned from a low of $31.01 to a high of $32.35. Yesterday, the shares fell 5.7%, which took the trading range below the 3-day low of $32.77 on volume of 4.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ANF: 29.50 (-5.88)

SmarTrend Watching for Potential Rebound in Shares of Abercrombie & Fitch After 5.71% Loss
Comtex SmarTrend(R) - Fri Oct 24, 5:39PM CDT
Abercrombie & Fitch (NYSE:ANF) traded in a range yesterday that spanned from a low of $31.01 to a high of $32.35. Yesterday, the shares fell 5.7%, which took the trading range below the 3-day low of $32.77 on volume of 4.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ANF: 29.50 (-5.88)

Downgrade Alert for Abercrombie & Fitch (ANF)
Comtex SmarTrend(R) - Fri Oct 24, 6:59AM CDT
Abercrombie & Fitch (NYSE:ANF) was downgraded from Neutral to Sell at Goldman Sachs today. The stock closed yesterday at $33.61 on volume of 2.6 million shares, above average daily volume of 2.3 million. Abercrombie & Fitch Co. is a specialty retailer that operates stores selling casual apparel, such as knit shirts, graphic t-shirts, jeans, woven shirts and personal care and other accessories for men, women and kids. The Company operates stores in the United States and Canada as well as retails its products over the Internet.
ANF: 29.50 (-5.88)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 8

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

HeartCore's Journey: From Nasdaq Challenges to Growth Potential

Updated Category News Views 35

HeartCore's Nasdaq Delisting Challenge HeartCore Enterprises, Inc. (NASDAQ:HTCR), a provider of enterprise software and consulting services, is currently facing a significant challenge related to its listing on the Nasdaq Capital Market. The company has received notice of non-compliance with the minimum bid price requirement, which mandates that its stock price must be at...

Continue Reading
Mitchell Capital Expands Portfolio with Optelos Acquisition

Updated Category News Views 236

Mitchell Capital's New Acquisition of Optelos Mitchell Capital, a prominent private equity firm, recently announced a significant acquisition that marks a pivotal moment for their long-term investment strategy. They have secured a controlling interest in Optelos, a distinguished provider of digital twin platforms that are tailored for enhancing critical infrastructure...

Continue Reading
Tampa Bay Lightning and Scripps Sports Forge Exciting Partnership

Updated Category News Views 247

Partnership Announcement Between Tampa Bay Lightning and Scripps Sports The Tampa Bay Lightning have officially entered into an exciting multi-year partnership with Scripps Sports. This collaboration signifies a new chapter for the Tampa Bay Lightning, expanding their reach in broadcasting and enhancing viewer engagement with National Hockey League (NHL) games. Through...

Continue Reading
Kazia Therapeutics Sets Meeting with FDA on Glioblastoma Treatment

Updated Category News Views 61

Kazia Therapeutics Prepares for FDA Meeting on Paxalisib Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is set to meet with the U.S. Food and Drug Administration (FDA) to explore potential pathways for the registration of its innovative drug, Paxalisib, aimed at treating newly diagnosed glioblastoma multiforme (GBM). This crucial...

Continue Reading
Important Notice for Flux Power Investors on Lead Plaintiff Claims

Updated Category News Views 100

Overview of Flux Power Investor Claims Investors with concerns regarding their investments in Flux Power Holdings, Inc. (NASDAQ: FLUX) have much to consider as recent developments unfold. The national securities law firm, Faruqi & Faruqi, LLP, is actively investigating claims that could impact investor interests and is eager to assist those affected. Critical Investment...

Continue Reading